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Purpose: To delineate a catastrophic childhood epileptic syndrome of unknown cause presenting with persistent intractable
multifocal status.
Methods: Case note review.
Results: Six children aged 5 months to 6 years presented with focal seizures that progressed within days to intractable multifocal
seizures with or without secondary generalisation, which recurred every few minutes and persisted for weeks. One developed
impaired consciousness shortly before seizures started. The two younger children showed mild developmental delay before
onset but the others were normal. The seizures were unresponsive to all conventional anticonvulsants, steroids or pyridoxine
and could only be controlled with doses of thiopentone sufficient to cause electrical suppression. MRI scans were initially
normal but later showed focal cortical swelling followed by generalised atrophy. Two developed hepatomegaly, with a normal
liver biopsy in one and steatosis in the other. No cause has been found even after neuropathological investigation. Three
have died, two within 3 months of onset, while the three survivors have very severe neurological impairment and continued
seizures.
Conclusion: The similarity of the clinical features suggests that this is a consistent clinical syndrome.
© 2003 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Acute onset intractable status can be the presentation
of several catastrophic childhood epileptic encephalo-
pathies, including Alpers–Huttenlocher syndrome,
pyridoxine dependency and other metabolic, infective
or malformative conditions. In recent years six chil-
dren have presented to different UK centres with focal
or multifocal status and a devastating acute epileptic
encephalopathy culminating in death or severe disabil-
ity. No treatment was effective and no cause has been
identified. The lack of explanation or even apparent
recognition of the syndrome adds to the difficulties of
parents trying to come to terms with the sudden loss of
a previously healthy child. Delineating the syndrome
will allow further study and should help in counselling
parents.
METHODS
Case notes review of affected children.
RESULTS
Clinical features are summarised in Table 1. The six
patients were aged between 5 months and 6 years
10 months at presentation. Two had a distant family
history of epilepsy, not affecting immediate family
members, sibs or cousins. Most were developmentally
normal before the onset of their symptoms. All had
normal head circumference measurements on presen-
tation. Patient 2 was not recognised to have mild de-
lay before presentation but a review of family videos
suggested this retrospectively. Four had non-specific
symptoms suggestive of infection immediately before
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Table 1: Clinical features.
Patient ID
1 2 3 4 5 6
Age at onset/sex 5 months/male 2 years 3 months/male 4 years 1 month/female 4 years 10 months/male 6 years 10 months/female 6 years 10 months/male
Family history Maternal uncle died in
status age 21 years
None None Maternal aunt seizures
due to DNET
None None
Antecedent history Mild delay; visual
impairment and
nystagmus; no acute
illness
Mild global delay
(retrospective from
family videos);
mildly/non specifically
unwell for few days
Normal development;
URTI/fever 4 days before
onset
Normal development;
abdominal pain,
headache and vomiting 6
days before onset
Normal development;
fever 48 hours, reduced
visual acuity and disc
swelling 24 hours
Normal
Seizures Twitching/rotating arms Stares Stares Apnoea with left gaze
deviation, left facial
twitching ± limb
twitching
Generalised twitching GTCS
Erratic myoclonus Tonic Left focal clonic EPC: left and occasional
right (later triggered by
movement or noise)
Multifocal jerks
especially facial, with
salivation
Tonic + apnoea Multifocal clonic (later
triggered by handling)
GTCS (Status) Myoclonic jerks
Number/day 3–4/day at first, >1/hour
by 72 hours, later status
4–12 hourly at first;
several/hour by 48 hours,
later status
Very frequent by 24 hours 2–3 hourly by 48 hours,
later status
Very frequent by 48 hours Status by 24 hours
EEG Early: right focal onset,
normal background, IPS:
slow wave activity; later:
electrical status; +3m:
slow background; isolated
temporal sharp waves
Burst suppression (on
thiopentone); interictal:
multifocal spikes with
attenuated background,
ictal: right or left focal
onset with rapid
generalisation
Early: left temporal onset
with spread to right;
+5m; moderately
abnormal background
with right and left sided
temporal discharges
Generalised slowing with
multifocal discharges
Electrical status at onset;
later epileptiform bursts
at 5–10 second intervals
Burst suppression (on
thiopentone); diffuse
slow; multifocal fast
spikes
Neurological
outcome
Became hyperreflexic At first normal between
seizures; 2 days later
unresponsive
Intractable frequent
multifocal motor
seizures; severe
asymmetric
extrapyramidal
quadriplegia; nasogastric
feeds; absent responses
to auditory and visual
stimuli
Intractable seizures;
hypotonic with brisk
reflexes; still able to
move limbs; severe
cognitive and
behavioural disturbances
Intractable frequent
multifocal motor
seizures; severe four
limb hypertonic
quadriplegia; nasogastric
feeds; some response to
auditory stimuli
Unresponsive by
36 hours; tetraplegic
(immobile apart from
seizures) with
hyperreflexia;
gastrostomy feeds;
tracheostomy
Age at death or last
follow-up
Died aged 8 months
(withdrawal IPPV)
Died aged 2 years 4
months (on IPPV)
4 years 8 months 5 years 6 months 10 years 8 months Died aged 9 years 1
month
Key: DNET = dysembryoplastic neuro-epithelial tumour; +m = number of months after onset; EPC = epilepsia partialis continua; GTCS = generalised tonic clonic seizures; IPS = intermittent photic
stimulation; IPPV = intermittent positive pressure ventilation.
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onset although later investigation did not identify an
infectious cause or pathology. Patient 5 had an acute
reduction in visual acuity with disc swelling sugges-
tive of papillitis immediately before the onset but MR
imaging 2 weeks later showed no evidence of demyeli-
nation or optic nerve compression.
They presented with clinical and electrical features
of focal or multifocal seizures that increased in fre-
quency and severity over 1–3 days, developing into
intractable status. Treatment with a wide range of
different agents was completely ineffective, except
at high enough doses to cause electrical suppression
(Table 2). As well as conventional anticonvulsants,
immunosuppressive agents were unhelpful. Three
children died. The three survivors all showed persist-
ing intractable multifocal seizures and severe cogni-
tive and motor sequels, that rendered two completely
dependent for all care including feeding.
Investigations failed to show a cause (Tables 3–5).
There was no positive evidence of a metabolic or
inflammatory cause. Three had increased urinary sul-
phite excretion without increased urinary thiosulphate,
low urate levels or consistently abnormal purine re-
sults. Lactate levels in blood and CSF were initially
normal but rose later in some. Specific and non-
specific markers of infection and auto-immune activ-
ity in CSF were normal. An electroretinogram (ERG)
was of low amplitude in the youngest patient, but was
not studied in the others. Neuro-imaging was normal
at first, but after a few weeks showed focal or gen-
eralised cortical swelling followed after 3–4 months
by generalised atrophy. Later scans also showed an
abnormal white matter signal on T2 weighted images.
Histopathological studies of the liver showed
non-specific fatty change in three biopsies and mild
Table 2: Medication administered.
Patient ID
1 2 3 4 5 6
Phenobarbitone + + + + + (primidone) +
Phenytoin + (initial partial effect) + + + + +
Carbamazepine + + + + +
Valproate + + + + + +
Vigabatrin + + + + +
Lamotrigine + + + + +
Diazepam + + + + +
Clonazepam + + +
Paraldehyde + + + + +
Chlormethiazole + + + + +
Lignocaine + + + + +
Midazolam + + +
Thiopentone + + + + + +
Prednisolone + +
Dexamethasone + + + +
Pyridoxine 100 mg/day for 10 days 400 mg stat + + + 100 mg/day
for 10 days
Other Lorazepam, biotin Biotin Propofol, Mg, biotin,
IVIG, plasmapheresis
IVIG
Key: IVIG = intravenous immunoglobulin; Mg = magnesium.
peri-portal inflammation in one at post-mortem. None
of the changes expected in Alpers–Huttenlocher syn-
drome were seen. Neuro-pathological findings were
very non-specific. In patient 1 at post-mortem changes
were minimal, with slight gliosis in the cerebral white
matter and scattered grey heterotopias in the cerebel-
lar white matter only. In patient 2 at post-mortem the
cerebellar cortex was moderately depleted of Purk-
inje cells and gliotic; the putamen, subcortical white
matter and internal capsule contained scattered min-
eralisations; the thalamus demonstrated considerable
neuronal loss and gliosis with numerous degenerate
neurons and ferrugination of these residua; and the
cerebral cortex showed a laminar pattern of corti-
cal destruction. All these features can be considered
hypoxic–ischaemic in origin. In patient 5 brain biopsy
showed non-specific changes in the cerebral cortex,
including ischaemic cell changes in some neurons,
reactive astrogliosis and scattered macrophages. In
patient 6 at post-mortem principal findings in the
brain included severe global end-stage cerebellar cor-
tical atrophy and sclerosis with lesser neuronal loss
and gliosis in the dentate and inferior olivary nu-
clei, and subtle loss of pontine nuclei; considerable
though patchy neuronal loss and gliosis in the thala-
mus where there was encrusted (mineralised) debris,
and patchy superficial destruction of the cerebral
cortex.
CASE REPORT (PATIENT 2)
This boy presented at 2 years with a 3-day history
of being ‘off colour’ followed by an episode of
staring, pallor and vomiting and later 10 minutes of
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Table 3: Haematology and biochemistry results (blood).
Patient ID
1 2 3 4 5 6
Blood count Normal Initial leucopenia Normal Normal Normal
Coagulation Normal Normal Normal Normal
Urea, electrolytes Normal Normal Normal Normal Normal
Ca/Mg Normal Normal Normal Normal Normal
Liver function Normal Normal Normal Normal Normal
Thyroid function Normal Low T4 TSH Normal Low free T4, normal TSH
Creatine kinase Normal Low Normal Normal
Ammonia Normal Normal Normal Normal Normal Normal
Aminoacids: blood Normal Normal Normal Normal Normal
Aminoacids: urine Normal Normal Normal Normal Normal Normal
Organic acids: urine Normal Normal Normal Normal Normal
VLCFA Normal Normal Normal Normal
Heavy metals Pb, Zn: normal Pb, Hg: normal Pb, Zn, Mn, Se: normal Pb, Se: normal
Copper 54.8 mg/dl (70–140) Normal Normal Normal Normal
Caeruloplasmin Normal Normal Normal Normal Normal
Urate 3.0; 3.2 mg/dl (3.4–7.6) Normal Normal
Purine/pyrimidine Xanthine 22.9 mg/g;
creatinine (<6.7),
hypoxanthine 32.5 mg/g
creatinine (<13.2)
Normal Normal
Sulphite urine +1m: negative; +3m:
present*
Present Slight increase (on
heminevrin and
morphine)
Uric acid urine Normal
Oligosaccharides 6m: negative; 8m: present Normal
White cell enzymes Normal Normal
Blood lactate 1.9 mEq/l (0.4–1.4) Normal at first; later 5.0
and 3.5 mEq/l
0.7; later 2.23 mEq/l 0.4m Eq/l Normal Normal
Other Intermediary metabolites
and biotinidase: normal
Cholesterol, triglycerides
and biotinidase: normal
Cholesterol, triglycerides
biotinidase and AFP:
normal
Chromosomes and
biotinidase: normal
Key: normal range in parentheses; TSH = thyroid stimulating hormone; +m = number of months after onset; VLCFA = very long chain fatty acids; ∗on treatment with sulphur containing drug
(cefotaxime); AFP = alphafoetoprotein.
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Table 4: CSF investigations and screens for infection.
Patient ID
1 2 3 4 5 6
CSF lactate 1.5 mEq/l 1.6 mEq/l 1.9; later 3.05 mEq/l 1.4 mEq/l Normal Normal
Mitochondrial DNA Normal Normal
Respiratory chain
enzymes (muscle)
Normal Normal Normal
CSF glycine (ratio) Normal Normal
CSF glucose 62.9 mg/dl 64.7 mg/dl 62.9 mg/dl 66.5 mg/dl 64.7/48.6 mg/dl Normal
CSF protein 88 mg/dl
(20–40)
11 mg/dl 30 mg/dl 30 mg/dl 65/42 mg/dl Normal
CSF cells None None 3 leukocytes <3 leukocytes 9 leukocytes/none on
repeat
None
Other CSF serine, HVA,
5H1AA: normal
Viral serology (blood) Normal Normal Normal Normal Normal
CSF IgG Normal Normal
CSF albumin 61.6 mg/dl (0–40) Normal
Oligoclonal bands Negative Negative Negative Negative
CSF PCR HSV: negative HSV: negative HSV, EBV, CMV,
HHV6: negative
HSV, VZV, EBV,
CMV, enteroviruses:
negative
HSV: negative All negative
Viral culture Stool: negative Urine, stool, CSF:
negative
Negative CSF: negative Negative
Serum IgG, A and
M levels
Normal IgG 400 mg/dl
(600–1700); IgA
60 mg/dl (70–350);
IgM normal
Normal
Autoimmune screen Normal Lupus autoantibody
equivocal; rest normal
Normal (including
anti-thyroid
antibodies)
Normal Normal
Key: HSV = herpes simplex virus; VZV = varicella zoster virus; EBV = Epstein–Barr virus; CMV = cytomegalovirus; HHV6 = herpes hominis virus 6.
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Table 5: Electrophysiological, neuro-imaging and histopathological results.
Patient ID
1 2 3 4 5 6
ERG Low amplitude
VEP Normal Asymmetric amplitude of
cortical potentials
CT Normal +1d: normal; +12d:
normal
Normal Normal Normal 1st week: normal
MRI +3m: mild atrophy; deep
white matter volume
reduced; high
periventricular signal on
T2; delayed myelination
+3w: impaired white
matter development with
diffusely increased
signal; mild increase
ventricular size
+3d: normal; +12d:
bright hippocampi; +1m:
generalised cerebral
atrophy with signal
change in periventricular
white matter +2m:
diffuse atrophy especially
of temporal horns;
shrunken hippocampi;
signal change in white
matter; spine normal
+2w: normal; +3w:
normal; +9w: swelling
left superior, middle and
inferior temporal gyrus
with high signal in the
grey matter
+15d: normal; +1m:
swollen cortex with
abnormal white matter
signal especially on T2
weighting; +4m:
generalised atrophy;
symmetrical signal
change in thalamus,
putamen and caudate
+1m: normal; +4m:
diffuse atrophy of both
hemispheres, brain stem
and cerebellum;
increased T2 signal
intensity symmetrically
in periventricular white
matter, maximal in
frontal/parietal-occipital
regions with some
sparing of subcortical
white matter; no signal
change brainstem or
cerebellum
Other Ictal SPECT scan:
hyperperfusion of right
posterior frontal region;
cerebral angiography:
normal
Liver Biopsy and PM: normal Biopsy: microvesicular
steatosis; PM: mild
periportal inflammation
Biopsy: non-specific
fatty infiltrate
PM: mild periportal
inflammation
Muscle biopsy Normal Normal Normal Normal
Brain (see text) PM: minimal changes PM: hypoxic ischaemic
changes
Biopsy: non-specific
change
Severe cerebellar cortical
atrophy; patchy changes
elsewhere
Key: +d = number of days after onset; +w = number of weeks after onset; +m = number of months after onset; PM = post-mortem.
Fig. 1: EEG in patient 2 recorded on day 5, showing the onset of a right sided seizure and multifocal spikes.
Fig. 2: EEG in patient 2 recorded on day 20, showing bursts of generalised polyspike activity, some related to stimulation, with
an attenuated background.
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generalised jerking. There was no antecedent or fam-
ily history. Details of his developmental progress and
review of family videos suggested mild developmen-
tal delay (cruising, crawling, first words at 15 months,
walking between 18 and 20 months; five single words
and no phrases at 24 months). Two hours later he be-
came unresponsive with tonic posturing and mouthing
which responded partially to intravenous diazepam
2.5 mg. After 15 minutes, his respiratory effort deteri-
orated and he was intubated and ventilated. Over the
next 48 hours, he had increasingly frequent episodes of
staring with lip smacking, tonic seizures with apnoea,
tonic posturing of the upper limbs, right and/or left
sided clonic movements, and generalised tonic clonic
seizures, that occurred up to four times an hour for
anything from a few seconds to 3 or 4 minutes dura-
tion. His conscious level deteriorated with asymmetri-
cal decorticate posturing to pain. This coincided with
increasing amounts of anticonvulsant treatment. Di-
azepam, paraldehyde and phenytoin were ineffective:
only thiopentone sufficient to cause electrical burst
suppression controlled his seizures. His seizures con-
tinued until death both clinically and on cerebral func-
tion monitoring. The initial ictal EEG showed a focal
onset at different sites with generalisation followed by
attenuation, while interictal recording showed multifo-
cal spike activity (Fig. 1). Later EEGs showed suppres-
sion with high dose barbiturates or bursts of polyspike
activity with an attenuated background (Fig. 2). In-
vestigations and treatment modalities are listed below
(Tables 2 and 3). His MRI brain scan showed diffuse
white matter changes and a focal area of hyperintensity
in the left posterior thalamus. Over the last 5 days, his
condition deteriorated with the development of pro-
teinuria, cardiac failure despite ionotropic support, and
finally hepatomegaly with jaundice and raised aspar-
tate aminotransferase (82 U/l, upper limit of normal
45) but normal alanine aminotransferase levels. Liver
and muscle were obtained immediately after death and
snap frozen: the liver showed microvesicular steatosis
and muscle was normal. Post-mortem findings were
described earlier.
DISCUSSION
These children had a strikingly similar clinical syn-
drome comprising preceding normal or mildly delayed
development, a sudden onset of uni- or multi-focal
seizures building up to status over a few days, al-
most total unresponsiveness to all anticonvulsants, and
death or severe neurological disability with cortical
atrophy as the sequel. However, extensive investiga-
tions including neuropathology failed to provide an
explanation. MRI findings were non-specific. Three
had positive urinary sulphite tests without other clin-
ical or biochemical features of molybdenum cofactor
or sulphite oxidase deficiency, possibly explained by
drug interference. No other positive metabolic, infec-
tious, inflammatory or structural abnormalities could
be demonstrated. In those who survived more than
2–3 months global brain atrophy developed on MRI,
associated on post-mortem with neuronal loss most
marked in the cerebellum. While the neuropathologi-
cal findings suggest that of these a metabolic cause is
the most probable, none had any family history sug-
gestive of a recessive condition.
Acute onset intractable status persisting for weeks
is an unusual presentation which is poorly described
in standard texts. Recognised conditions which can
present in a similar way were excluded in our cases.
Alpers–Huttenlocher syndrome can be excluded on
the basis of normal liver function tests, normal liver
histopathology and the absence of the characteristic
EEG findings1. Poliodystrophies were also excluded
by the absence of histopathological changes in the
brain: although changes can sometimes be focal, it
would be surprising to have missed these in four sep-
arate patients who were specifically examined for this
diagnosis. Storage disorders were excluded on sim-
ilar grounds. Pyridoxine dependency was formally
excluded by trials of treatment, but the clinical course
would not have been typical in the older children.
Molybdenum cofactor and sulphite oxidase deficiency
usually present with neonatal seizures, hypotonia and
a cavitating leucodystrophy, associated with charac-
teristic biochemical abnormalities. Later onset cases
have not presented with intractable seizures alone2.
None of our patients had a trial of folinic acid, re-
cently shown to be effective in some neonatal onset
seizures3. Cat scratch disease encephalopathy can
present with status in previously healthy children but
full recovery usually occurs within 2 weeks and EEGs
typically show diffuse slow wave activity4, 5. However
one case has been described with persisting seizures,
visual disturbance and focal MRI changes6. Four of
our cases presented with a prodromal illness, two
with fever, suggesting an infective cause and although
no evidence of this was found on neuropathology this
cannot be excluded. However inflammatory conditions
including auto-immune disorders still seem unlikely in
view of the lack of positive neuropathological findings
and of any response to immunomodulatory therapy.
A similar syndrome may have been described in
Japanese children by Awaya et al. at the International
League against Epilepsy meeting in Dublin in 1995
(Peculiar type of post-encephalitic epilepsy: a new
syndrome?). They described 24 children aged 3–15
years at onset with intractable partial seizures and sub-
sequent developmental delay, but details are too sparse
for full comparison. The clinical course does not ap-
pear as devastating as in our patients. They suggest
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a viral aetiology in their patients, 40% of whom had
a CSF pleocytosis. Coppola et al.7 have described 14
infants with multifocal seizures beginning between 13
days and 7 months of age which became frequent and
intractable by 1–10 months, who became quadriplegic.
No cause was found. Neuropathology showed hip-
pocampal neuronal loss and gliosis in two patients.
Eight who were tested had reduced b waves in their
ERG. This resembles our first patient, but the others
differ in the age of onset. One case report describes
a previously healthy 7-year-old who followed a sim-
ilar course to our cases and survived with continuing
seizures and diffuse atrophy on MRI after 70 days of
high dose polytherapy8.
One striking feature is the total lack of response to
therapy. As in the case report cited above8, only drugs
such as barbiturates at levels that caused electrical sup-
pression could stop the seizures. This is difficult to ex-
plain. Resistant seizures following acute symptomatic
aetiologies such as infection or trauma usually resolve
in a few days. If our children had acute pathologies
the effect on the brain persisted for much longer. One
hypothesis would be that children may have had a var-
ied aetiology to the onset of their seizures but that they
have a common cause to their persistence and lack of
response to treatment. This requires further evaluation.
These children were distressing to manage as
all medical interventions were so ineffective. Their
parent’s and family’s bereavement was not helped by
the lack of any explanation and by the lack of any
syndromic diagnosis. Delineation of the syndrome is
a first step to more effective management.
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